Trials / Sponsors / Phoenicis Therapeutics
Phoenicis Therapeutics
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Dystrophic Epidermolysis Bullosa | Phase 1 / Phase 2 | 2023-04-30 |
| Unknown | Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa Hidradenitis Suppurativa | Phase 2 | 2022-05-05 |
| Terminated | A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Saf Epidermolysis Bullosa Dystrophica, Recessive, Epidermolysis Bullosa Dystrophica, Dominant | Phase 1 / Phase 2 | 2018-07-02 |